Caplin Point Laboratories (BOM:524742) Days Sales Outstanding : 109.27 (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories Days Sales Outstanding?

Caplin Point Laboratories's average Accounts Receivable for the three months ended in Mar. 2024 was ₹5,427 Mil. Caplin Point Laboratories's Revenue for the three months ended in Mar. 2024 was ₹4,532 Mil. Hence, Caplin Point Laboratories's Days Sales Outstanding for the three months ended in Mar. 2024 was 109.27.

The historical rank and industry rank for Caplin Point Laboratories's Days Sales Outstanding or its related term are showing as below:

BOM:524742' s Days Sales Outstanding Range Over the Past 10 Years
Min: 4.17 Med: 82.19 Max: 100.92
Current: 100.24

During the past 13 years, Caplin Point Laboratories's highest Days Sales Outstanding was 100.92. The lowest was 4.17. And the median was 82.19.

BOM:524742's Days Sales Outstanding is ranked worse than
74.85% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs BOM:524742: 100.24

Caplin Point Laboratories's Days Sales Outstanding increased from Mar. 2023 (92.37) to Mar. 2024 (109.27).

Caplin Point Laboratories Days Sales Outstanding Historical Data

The historical data trend for Caplin Point Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Days Sales Outstanding Chart

Caplin Point Laboratories Annual Data

Trend

Jun15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

84.01

88.50

86.18

88.86

100.92

Caplin Point Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															92.37	90.96	102.14	96.17	109.27

Competitive Comparison of Caplin Point Laboratories's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caplin Point Laboratories's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Days Sales Outstanding falls into.

Caplin Point Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Caplin Point Laboratories's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (3940.6	+	5427.2)	/	2 )	/	16941	*	365
=	4683.9					/	16941	*	365
=	100.92

Caplin Point Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	5427.2)	/	1 )	/	4532.2	*	365 / 4
=	5427.2					/	4532.2	*	365 / 4
=	109.27

Caplin Point Laboratories (BOM:524742) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Caplin Point Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Caplin Point Laboratories (BOM:524742) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

CAPLIPOINT:India

Address

Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096

Website

https://www.caplinpoint.net

Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines